103. Defining the pleiotropic GATA2 deficiency phenotype for the development of ACMG-AMP GATA2 variant curation rules
Taylor Walker(Northwestern University), Lucy A. Godley(University of Chicago), Marcin W. Włodarski(St. Jude Children's Research Hospital), Guimin Gao(Chicago Department of Public Health), Panagiotis Baliakas(Uppsala University), Katherine R. Calvo(National Institutes of Health Clinical Center), Shruthi Mohan(University of North Carolina at Chapel Hill), Eran Tallis(Baylor College of Medicine), David T. Wu(Harvard University), Sioḃán Keel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Simone Feurstein(Heidelberg University), Xi Luo(Chinese Academy of Sciences), Amy P. Hsu(National Institute of Allergy and Infectious Diseases)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
|Nature|2008|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889